- Home
- CANF vs MNR Comparison
CANF vs MNR Comparison
Compare CANF & MNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CANF | MNR |
|---|---|---|
| Founded | 1994 | 2017 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4M | 2.1B |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | CANF | MNR |
|---|---|---|
| Price | $4.39 | $13.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $9,750.00 | $20.00 |
| AVG Volume (30 Days) | 74.2K | ★ 297.5K |
| Earning Date | 03-27-2026 | 03-12-2026 |
| Dividend Yield | N/A | ★ 21.93% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.92 |
| Revenue | $560,000.00 | ★ $956,307,000.00 |
| Revenue This Year | $461.72 | $21.02 |
| Revenue Next Year | N/A | $30.15 |
| P/E Ratio | ★ N/A | $13.57 |
| Revenue Growth | N/A | ★ 9.45 |
| 52 Week Low | $3.36 | $10.46 |
| 52 Week High | $46.60 | $16.65 |
Technical Indicators
Market Signals| Indicator | CANF | MNR |
|---|---|---|
| Relative Strength Index (RSI) | 61.93 | 69.28 |
| Support Level | $4.02 | $12.48 |
| Resistance Level | $4.74 | $11.85 |
| Average True Range (ATR) | 0.28 | 0.38 |
| MACD | -0.12 | 0.14 |
| Stochastic Oscillator | 29.73 | 96.94 |
Price Performance
Historical ComparisonAbout CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)
Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.
About MNR Mach Natural Resources LP
Mach Natural Resources LP is an independent upstream oil and gas company. The company is focused on the acquisition, development and production of oil, natural gas, and NGL reserves in the Anadarko Basin region of Western Oklahoma, Southern Kansas, and the panhandle of Texas.